| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/29/2010 | CN1948342B HLA-A2 restriction epi polypeptide originated from post selection cancer gene hRabj and its application |
| 12/29/2010 | CN1926132B Pyrazole compounds useful as protein kinase inhibitors |
| 12/29/2010 | CN1922139B Bicyclic amide derivatives |
| 12/29/2010 | CN101932939A Marker for determination of sensitivity to anti-cancer agent |
| 12/29/2010 | CN101932608A Antigen-binding constructs |
| 12/29/2010 | CN101932604A Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 12/29/2010 | CN101932602A Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 12/29/2010 | CN101932592A Antitumoral compounds |
| 12/29/2010 | CN101932587A Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 12/29/2010 | CN101932586A Inhibitors of protein tyrosine kinase activity |
| 12/29/2010 | CN101932584A Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof |
| 12/29/2010 | CN101932583A Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors |
| 12/29/2010 | CN101932580A Imidazopyridine kinase inhibitors |
| 12/29/2010 | CN101932572A Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide |
| 12/29/2010 | CN101932565A Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor |
| 12/29/2010 | CN101932564A Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 12/29/2010 | CN101932338A Method for determination of sensitivity to anti-cancer agent |
| 12/29/2010 | CN101932335A Medicament for the treatment of cancer of the pancreas |
| 12/29/2010 | CN101932325A Ido inhibitors |
| 12/29/2010 | CN101932318A Composition for stimulating natural killer cell activity |
| 12/29/2010 | CN101932310A Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
| 12/29/2010 | CN101928747A Application of E3 ubiquitin ligase CHIP in gliomatosis cerebri disease |
| 12/29/2010 | CN101928740A MMP14 double-target efficient binding peptide, method for obtaining polypeptide structure sequence and application of target compound |
| 12/29/2010 | CN101928705A Experimental technique for transforming fungal secondary metabolism and use thereof |
| 12/29/2010 | CN101928696A Preparation and application of prostate cancer targeting adenovirus |
| 12/29/2010 | CN101928692A Differentiated cells suitable for human therapy |
| 12/29/2010 | CN101928347A Anti-carcinoembryonic-antigen (CEA) antibody and application thereof |
| 12/29/2010 | CN101928345A Human source antibody and humanization remolding method thereof |
| 12/29/2010 | CN101928344A Human monoclonal antibodies against cd20 |
| 12/29/2010 | CN101928335A Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof |
| 12/29/2010 | CN101928329A Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 12/29/2010 | CN101928327A Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| 12/29/2010 | CN101928326A Substitution five-heterocyclic alkyl aminoacyl compound and application thereof |
| 12/29/2010 | CN101928323A 23-hydroxy betulinic acid derivative with modified sites 3, 23 and 28 as well as preparation method, preparation and application thereof |
| 12/29/2010 | CN101928322A Ursolic acid modifier polyol monoesters with anti-cancer activity |
| 12/29/2010 | CN101928321A Acidic amino acid chemically-modified ursolic acid derivatives with anti-cancer activities |
| 12/29/2010 | CN101928293A Bisindole alkaloid compound, medicine composition thereof and preparation method and application of medicine composition |
| 12/29/2010 | CN101928288A Small molecule compositions for binding to HSP90 |
| 12/29/2010 | CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 12/29/2010 | CN101928279A 3-amino-2-pyrones cyclooxygenase inhibitors as well as preparation method and application thereof |
| 12/29/2010 | CN101928270A Isobenzofuranone compound, preparation method thereof and use thereof |
| 12/29/2010 | CN101928264A Apoptosis promoters |
| 12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
| 12/29/2010 | CN101928259A 2-arylthiazole derivative and medicament composition thereof |
| 12/29/2010 | CN101928258A 1-(2-substituted phenylamino-4-methyl-thiazole-5)-3-substituted phenyl-acrylketone derivative, preparation method and pharmaceutical application thereof |
| 12/29/2010 | CN101928254A Benzotriazole derivatives and preparation method and use thereof |
| 12/29/2010 | CN101928245A 8-hydroxyl or methoxyl-2-aryl-1-isoquinolines, synthesis method and application thereof |
| 12/29/2010 | CN101928243A Acenaphtho heterocyclic compounds, and cyclodextrin inclusion compounds or conjugates thereof and application thereof in preparing Bcl-2 family protein inhibitors |
| 12/29/2010 | CN101928241A 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them |
| 12/29/2010 | CN101928234A 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same |
| 12/29/2010 | CN101927008A Diagnostic and therapeutic gastric cancer vascular specific binding peptide GEBP11 isotope probe |
| 12/29/2010 | CN101927001A Method for loading anti-cancer drug based on multifunctional polyamidoamine dendrimer |
| 12/29/2010 | CN101926993A Adjuvant systems and vaccines |
| 12/29/2010 | CN101926962A Hydroxypropyl-beta-cyclodextrin inclusion liposome of zedoary turmeric oil and preparation method thereof |
| 12/29/2010 | CN101926956A Chinese medicinal powder for treating mazoitis, hyperplasia of mammary glands and breast cancer |
| 12/29/2010 | CN101926921A Liriope muscari total saponin and preparation method thereof |
| 12/29/2010 | CN101926916A Chinese medicinal powder for treating tumor |
| 12/29/2010 | CN101926907A Method for preparing Kang'ai body resistance-strengthening tablets for treating tumors |
| 12/29/2010 | CN101926895A Chinese medicinal composition and preparation method and application thereof |
| 12/29/2010 | CN101926882A Medicinal composition for treating cancer and preparation methods thereof |
| 12/29/2010 | CN101926844A Stellera chamaejasme L extract and anti-tumor action thereof |
| 12/29/2010 | CN101926826A Method for extracting active ingredients from sea horse |
| 12/29/2010 | CN101926816A Intravenous injection of nelarabine and preparation method thereof |
| 12/29/2010 | CN101926812A New application of apigenin-7-O-beta-D-glucoside-4'-O-alpha-L-rhamnoside |
| 12/29/2010 | CN101926809A Pharmaceutical preparation and preparation method thereof |
| 12/29/2010 | CN101926797A New application of tetrahydropalmatine derivatives |
| 12/29/2010 | CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease |
| 12/29/2010 | CN101926786A Sustained release preparation for cantharidin and cantharidin extract |
| 12/29/2010 | CN101926780A Freeze-dried preparation of stabilized anthracycline compound |
| 12/29/2010 | CN101926779A Gemcitabine solid lipid nanospheres, preparation method thereof and use thereof |
| 12/29/2010 | CN101926775A Preparation and application methods of difunctional naonparticle preparation entrapping vincristine sulphate |
| 12/29/2010 | CN101926772A Polysaccharide nucleic acid fraction of bacillus calmette guerin lipid composition for livestock and freeze-dry preparation thereof |
| 12/29/2010 | CN101926770A Drug-loaded liposome and preparation method thereof |
| 12/29/2010 | CN101926503A Anti-cancer macrobiotic cigarette rich in trace elements selenium and germanium and having function of powerfully eliminating toxicity of tar smoke |
| 12/29/2010 | CN101618030B Triptolide transdermal patch and preparation method thereof |
| 12/29/2010 | CN101584669B Melphalan freeze-dried powder injection |
| 12/29/2010 | CN101574506B Method for preparing pingxiao preparation |
| 12/29/2010 | CN101560514B Bridge molecule 1-siRNA interference sequence and fusion expression vector thereof |
| 12/29/2010 | CN101502486B Antineoplastic 2-methoxyestradiol injection containing cyclodextrin or cyclodextrin derivates |
| 12/29/2010 | CN101497886B Polypeptide of fungal thioredoxin, coding sequence, preparation and use |
| 12/29/2010 | CN101485666B Application of Gamabufotalin and salt thereof in preparing medicament for treating gynaecologic tumor |
| 12/29/2010 | CN101463063B Method for synthesizing 3 alpha-hydroxy-2 beta-amidine-5 alpha-androst-17-keto compound |
| 12/29/2010 | CN101445504B Dioxane-2-alkyl carbamates derivatives |
| 12/29/2010 | CN101422466B Use of cucurbitacin in preparing medicine for treating cancer |
| 12/29/2010 | CN101342357B Chinese medicinal composition for treating gland hyperplasia and preventing and controlling mammary cancer |
| 12/29/2010 | CN101336925B Use of PS-341 in preparing medicine for synergistic inductive differentiation therapy of leukaemia |
| 12/29/2010 | CN101311188B Small molecule peptides inhibitor of human heparinase |
| 12/29/2010 | CN101265243B Method for refining docetaxel |
| 12/29/2010 | CN101214270B Acanthopanax senticosus effective fraction extract, preparation and application thereof |
| 12/29/2010 | CN101208339B Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 12/29/2010 | CN101208338B Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 12/29/2010 | CN101205234B Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
| 12/29/2010 | CN101200482B shRNA accelerating carcinoma cell apoptosis and uses thereof |
| 12/29/2010 | CN101200465B Decahydronaphthalene compounds and medical uses thereof |
| 12/29/2010 | CN101195032B Method for preparing coupled article of polyasparamide derivant and adriablastina, and uses thereof |
| 12/29/2010 | CN101160354B Polymeric pharmaceutical agent for treatment of cancer and process for production of the same |
| 12/29/2010 | CN101160130B Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome |
| 12/29/2010 | CN101142193B Propane-1,3-dion derivative or salt thereof |
| 12/29/2010 | CN101117348B A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof |
| 12/29/2010 | CN101098702B Drugs, food or drink for improving pancreatic functions |